In your opinion, where might the recent M&A examples have the most impact for consumers?
Cost: Collaborative efforts between payers and pharma could help to drive down costs
Quality: Individual companies’ greater emphasis in particular therapeutic areas could drive greater opportunity for personalized medicine
Access: Through value-based collaborations, consumers could gain more access to drugs that were previously off formulary
Vote
View Results
See this poll on:
https://poll.fm/8023709/embed